Commercialisation Of StereaxQualified manufacturing at Cirtec and initial cathode purchase orders move Stereax from development into early commercial supply. This reduces scale‑up and manufacturing risk, creates an initial repeatable revenue stream (cathode/NRE) and strengthens partner confidence over the coming months.
Goliath Prototyping And Scale-upShipping 10 Ah prototypes and running an automated pilot line, plus earlier 2 Ah validation, demonstrates manufacturability and process scalability. This compatibility with production equipment lowers technical and deployment risk and materially supports future licensing and OEM adoption timelines.
IP-backed, Asset-light Licensing ModelA licensing-focused, asset-light go-to-market model backed by 78 granted patents creates structural leverage: revenue from NRE, cathode deposition services and royalties scales without heavy capex. Strong IP improves bargaining power with partners and supports durable, capital-efficient commercialization.